A total of 11.75 hours of continuing
education credit for pharmacists, nurses and physicians is available in 9 JMCP
supplements created by the medical education company PRIME under contract
with the Agency for Healthcare Research and Quality (AHRQ) to increase
awareness and usefulness of AHRQ-sponsored reviews of findings in
patient-centered outcomes research, also known as comparative effectiveness
reviews (CERs).
“Methods
for Insulin Delivery and Glucose Monitoring in Diabetes: A Summary of
Comparative Effectiveness Review”– JMCP August 2012, 1.0 contact hour of CE/CME/CNE
accreditation.
“Summary
of the Comparative Effectiveness Review on Off-Label Use of Atypical
Antipsychotics”– JMCP June 2012, 1.5 contact hours of CE/CME/CNE
accreditation.
“Summary
of AHRQ’s Comparative Effectiveness Review of Treatment to Prevent Fractures in
Men and Women with Low Bone Density or Osteoporosis: Update of the 2007 Report”–JMCP
May 2012, 1.0 contact hour of CE/CME/CNE accreditation.
“Summary
of AHRQ's Comparative Effectiveness Review of Drug Therapy for Rheumatoid
Arthritis in Adults – An Update” – JMCP May 2012, 1.0 contact hour of
CE/CME/CNE accreditation.
“Summary
of AHRQ’s Comparative Effectiveness Review of Disease-Modifying Antirheumatic
Drugs for Children with Juvenile Idiopathic Arthritis” – JMCP
January/February 2012, 1.0 contact hour of CE/CME/CNE accreditation.
“AHRQ’s Comparative
Effectiveness Research on Oral Medications for Type 2 Diabetes: A Summary of
the Key Findings” - JMCP January/February 2012, 1.25 contact hours of
CE/CME/CNE accreditation.
"Updates
on the Treatment of Essential Hypertension: A Summary of AHRQ’s Comparative
Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors, Angiotensin
II Receptor Blockers, and Direct Renin Inhibitors" - JMCP October
2011, 1.0 contact hour of CE/CME/CNE accreditation.
“Summary
of AHRQ’s Comparative Effectiveness Review of Angiotensin-Converting Enzyme
Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical
Therapy for Treating Stable Ischemic Heart Disease” - JMCP June 2011, 1.0
contact hour of CE/CME/CNE accreditation.
“AHRQ’s
Comparative Effectiveness Research on Premixed Insulin Analogues for Adults
with Type 2 Diabetes: Understanding and Applying the Systematic Review
Findings” - JMCP April 2011, 3.0 contact hours of CE/CME/CNE accreditation.